VRCA
Verrica Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$99.98M
P/E Ratio
—
EPS
$-1.68
Beta
1.43
52W High
$9.82
52W Low
$3.28
50-Day MA
$5.92
200-Day MA
$5.97
Dividend Yield
—
Profit Margin
-50.30%
Forward P/E
—
PEG Ratio
—
About Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania.
Fundamentals
| Revenue (TTM) | $35.58M |
| Gross Profit (TTM) | $23.28M |
| EBITDA | $-11.45M |
| Operating Margin | -136.40% |
| Return on Equity | -240.40% |
| Return on Assets | -14.70% |
| Revenue/Share (TTM) | $3.34 |
| Book Value | $1.44 |
| Price-to-Book | 3.81 |
| Price-to-Sales (TTM) | 2.81 |
| EV/Revenue | 1.849 |
| EV/EBITDA | -11.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1380.00% |
| Shares Outstanding | $17.18M |
| Float | $6.78M |
| % Insiders | 48.25% |
| % Institutions | 30.26% |
Analyst Ratings
Consensus ($16.50 target)
4
Buy1
HoldData last updated: 4/9/2026